Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis

: Background/Aim: Liver steatosis (LS) has been variably associated with chronic hepatitis C (CHC) but whether it affects sustained virological response to antiviral treatment and by what mechanisms is a question still under debate, at least for some genotypes. The aim of this work was to assess the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Liver international 2006-11, Vol.26 (9), p.1119-1125
Hauptverfasser:	Soresi, M., Tripi, S., Franco, V., Giannitrapani, L., Alessandri, A., Rappa, F., Vuturo, O., Montalto, G.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aging Alanine Transaminase - blood Antiviral Agents - therapeutic use antiviral treatment Aspartate Aminotransferases - blood Body Mass Index chronic hepatitis C Drug Therapy, Combination Fatty Liver - complications Fatty Liver - pathology Female gamma-Glutamyltransferase - blood Genotype Hepacivirus - genetics Hepatitis C, Chronic - complications Hepatitis C, Chronic - drug therapy Hepatitis C, Chronic - physiopathology Hepatitis C, Chronic - virology Humans Interferon-alpha - therapeutic use Liver - pathology liver steatosis Male Middle Aged Polyethylene Glycols - therapeutic use Recombinant Proteins Ribavirin - therapeutic use Severity of Illness Index Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!